《艾昆纬：加拿大精神障碍药物治疗：2020-2024 年药物使用数据报告（英文版）（20页）.pdf》由会员分享，可在线阅读，更多相关《艾昆纬：加拿大精神障碍药物治疗：2020-2024 年药物使用数据报告（英文版）（20页）.pdf（20页珍藏版）》请在三个皮匠报告上搜索。

1、Medication Treatments for Mental Health Disordersin CanadaAn independent IQVIA report on drug utilization data,2020-20242|Medication Treatments for Mental Health Disorders in CanadaTable of contentsIntroduction 3Overview of the evolution of the use of drug treatments for mental health in Canada(2020

2、2024)5Demographic analysis 8Antidepressants 8Anxiolytics 10Antipsychotics 12Psychostimulants 14Recommendations for stakeholders in the health sector 17Limitations 17Data sources,methodology and list of molecules to Health Canada,mental illness is characterized by changes in a persons thinking,mood,o

3、r behaviour and is generally associated with significant distress or impairment in social,occupational,or other activities.Mental illness indirectly affects all Canadians at some point,either through their own experience or that of a family member,friend,or colleague.In any given year,one in five Ca

4、nadians suffers from a mental illness,and by the time Canadians reach the age of 40,one in two has suffered or is suffering from a mental illness.According to CIHI,nearly 13%of patients with a mental illness are hospitalized at least three times a year in Canada.1 Depending on the availability of me

5、ntal healthcare in different health regions,this ranges from one in 14 patients to one in four patients.In 2022,the economic issues related to mental health and disabilities cost Canada more than$220 billion,including$32 billion in direct expenses(about 10%of public health)and$190 billion in indirec

6、t losses,including worker downtime and presenteeism.2Although statistics on medication use were prioritized for the preparation of this report,other effective treatments and services are also available,including psychotherapy,helplines,virtual services/telemedicine,community supports,alternative med